Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing and able to agree to take part and give your consent to join the study
- You are 18 years old or older at the time of giving consent
- You need to have a lump or abnormal area in your breast or armpit lymph node marked and surgically removed
Who may not be able to join:
- You are pregnant, breastfeeding, or planning to become pregnant during the study follow-up period (a pregnancy test is required for all women who could potentially become pregnant within 7 days before joining)
- You have other health conditions, personal circumstances, or medical, social, or psychological factors that, in the opinion of the study doctor, could affect your ability to take part or follow the study requirements (confirm with trial site)
- You have a known allergy or sensitivity to a metal called Nitinol, which is commonly used in medical devices
- You currently have an active infection at the area of your breast where the device would be placed, as determined by the study doctor
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Stefan Paepke, Dr, The technical university of Munich
Phone: +447851247439
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The primary endpoints are the retrieval rates of the Magseed Pro® marker with the target lesion within the initial excised specimen for A.) axillary lymph nodes B.) breast lesions A.) axillary lymph nodes. B.) breast lesions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.